GSK plc vs Vale SA — how do they compare? GSK plc trades at $50.5 (market cap $102.60B), while Vale SA trades at $14.39 (market cap $61.97B). The key difference: GSK plc is the larger of the two by market cap, and Vale SA pays the higher dividend (8.35%). Which is the better fit depends on your goals.
| GSK | VALE | |
|---|---|---|
Market Cap | $102.60B | $61.97B |
Sector | Health | Basic Materials |
52-Week High | $61.18 | $17.82 |
52-Week Low | $38.22 | $9.71 |
Enterprise Value | $123.04B | $78.22B |
Dividend Yield | 3.57% | 8.35% |
Trailing returns across standard periods
Latest headlines on both assets
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →Vale is the world's largest iron ore miner and one of the largest diversified miners, along with BHP and Rio Tinto. Earnings are dominated by the bulk materials division, primarily iron ore and iron ore pellets, with minor contributions from iron ore proxies, including manganese and coal. The base metals division is much smaller, primarily consisting of nickel mines and smelters with a small contribution from copper.
Read more on VALE →